LISOCABTAGENE MARALEUCEL

UNII:	7K2YOJ14X0
Formula:
Preferred Substance Name:	LISOCABTAGENE MARALEUCEL

AUTOLOGOUS CD4+ AND CD8+ T CELLS EXPRESSING A CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR; COMPRISED OF AN FMC63 MONOCLONAL ANTIBODY-DERIVED SINGLE CHAIN VARIABLE FRAGMENT (SCFV), LGG-DERIVED SPACER, CD28 TRANSMEMBRANE DOMAIN, CD137 (4-1BB) COSTIMULATORY DOMAIN, AND CD3 ZETA SIGNALING DOMAIN) AND A TRUNCATED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFRT)
BREYANZI
JCAR017
JCAR-017
LISOCABTAGENE MARALEUCEL [INN]
LISOCABTAGENE MARALEUCEL [USAN]
LISOCABTAGENE MARALEUCEL [WHO-DD]

Inxight Drugs
i
DailyMed Regulated Products
i
GSRS Full Record
i
ITIS
i
NCBI Taxonomy
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LISOCABTAGENE MARALEUCEL

Synonyms and Mappings

Resources